CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 146 enrolled
Drug / intervention
ACUVUE® OASYS with Transitions™ +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04116736
NCT04116736N/ACompleted

ACUVUE® OASYS With Transitions™ Light Intelligent Technology™ Clinical Performance Registry

Johnson & Johnson Vision Care, Inc.·observational·Posted Oct 7, 2019·Updated May 23, 2025

In Brief

An observational study evaluating ACUVUE® OASYS with Transitions™ and Silicone Hydrogel Contact Lens for Vision Satisfaction in Bright Light. Completed, enrolled 146 participants across 22 sites in 2 countries.

Detailed Summary

This registry study is a one-year, one-visit, observational, prospective, open-label, two-arm, multi-center, multi-national, post-market study of approximately 300 patients who have recently been fitted with the ACUVUE® OASYS with Transitions™ and approximately 300 patients who have recently been fitted with spherical nonphotochromic reusable marketed silicone hydrogel contact lenses (of any brand). Eligible subjects will be asked to complete a Patient Registration Questionnaire several times throughout the year.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesSpain, United Kingdom
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedOct 7, 2019
Enrollment StartOct 19, 2019
Primary CompletionMar 10, 2023
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 6.7 years ago

Interventions

ACUVUE® OASYS with Transitions™device

JJVC Marketed Contact Lens

Silicone Hydrogel Contact Lensdevice

Any reusable spherical silicone hydrogel brand that is approved and marketed in the country conducting the study.